Rethinking the Ethical Principles of Genomic Medicine Services
JOHNSON S. et al, (2019), European Journal of Human Genetics
Evaluating the integration of genomics into cancer screening programmes: challenges and opportunities
Briggs S. and Slade I., (2019), Current Genetic Medicine Reports, 7, 63 - 74
Understanding and using patient experiences as evidence in healthcare priority setting.
Rand L. et al, (2019), Cost Eff Resour Alloc, 17
Genomics education for medical professionals - the current UK landscape.
Slade I. et al, (2016), Clin Med (Lond), 16, 347 - 352
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
George A. et al, (2016), Sci Rep, 6
A cost analysis of a cancer genetic service model in the UK.
Slade I. et al, (2016), J Community Genet, 7, 185 - 194
Preparing clinicians for genomic medicine.
Slade I. and Burton H., (2016), Postgrad Med J, 92, 369 - 371
Development of cancer genetic services in the UK: A national consultation.
Slade I. et al, (2015), Genome Med, 7
A genome-wide association study identifies susceptibility loci for Wilms tumor.
Turnbull C. et al, (2012), Nat Genet, 44, 681 - 684
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I. et al, (2011), Fam Cancer, 10, 337 - 342
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.
Slade I. et al, (2011), J Med Genet, 48, 273 - 278
DICER1 syndrome - a pleiotropic tumor predisposition syndrome
Slade I. et al, (2010), JOURNAL OF MEDICAL GENETICS, 47, S115 - S115
Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
Slade I. et al, (2010), J Med Genet, 47, 342 - 347